Numeros tematicos

• 2022

  • A Multi-Disciplinary Approach to Diagnosis and Management of Amyloidosis

    Volume 135 - Supplément 1, pp.S1-S58 (avril 2022)

• 2020

  • VTE Prophylaxis Consensus Statement supplement

    Volume 133 - Supplément 1, pp.1-28 (mai 2020)

• 2019

  • Heart failure and type 2 diabetes mellitus: exploring the role Sodium-glucose co-transporter 2 inhibitors

    Volume 132 - Número 10S, pp.S1-S58 (octobre 2019)

• 2018

  • The Challenge of Controlling the COPD Epidemic

    Volume 131 - Número 9S, pp.1-30 (septembre 2018)

• 2017

  • Cardiovascular Disease and Sodium Glucose Cotransporter 2 Inhibitors: A New Era for Type 2 Diabetes Mellitus

    Volume 130 - Número 6S, pp.A1-A4 (juin 2017)

• 2016

  • Reversal of Oral Anticoagulants

    Volume 129 - Número 11S, pp.A1-A4 (novembre 2016)

  • North American Thrombosis Forum AF Action Initiative Consensus Document

    Volume 129 - Número 5S, pp.A1-A8 (mai 2016)

• 2015

  • Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability

    Volume 128 - Número 9S, pp.A1-A8 (septembre 2015)

• 2014

  • Insulin Therapy in Type 2 Diabetes: A Reflection Upon the State of the Art Today, and the Potential Journeys yet to Come

    Volume 127 - Número 10S, pp.A1-A8 (octobre 2014)

  • Partnership for Anaphylaxis: Enhancing Recognition, Treatment, and Outcomes

    Volume 127 - Número 1S, pp.A1-A4 (janvier 2014)

• 2013

  • Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations

    Volume 126 - Numéro 10 Supplément 1, pp.A1-A4 (octobre 2013)

  • Changing Patterns in the Treatment of Type 2 Diabetes

    Volume 126 - Numéro 9 Supplément 1, pp.A1-A4 (septembre 2013)

  • Opioids in Chronic Pain: Evolving Best Practice Strategies

    Volume 126 - Numéro 3 Supplément 1, pp.A1-A4 (mars 2013)

• 2012

  • Myelodysplastic Syndromes

    Volume 125 - Número 7S, pp.A1-A4 (juillet 2012)

  • Invasive Mycoses: Evolving Challenges and Opportunities in Antifungal Therapy

    Volume 125 - Número 1S, pp.S1-S58 (janvier 2012)

• 2011

  • Challenges and Opportunities in the Management of the Hispanic/Latino Patient With Type 2 Diabetes Mellitus

    Volume 124 - Número 10S, pp.A1-A8 (octobre 2011)

  • Shared Experiences and Best Practices in the Management of Rheumatoid Arthritis and Crohn's Disease

    Volume 124 - Número 4S, pp.A1-A8 (avril 2011)

  • Exploring the Spectrum of Incretin Therapies: The Potential for Optimizing Patient Outcomes

    Volume 124 - Número 1S, pp.S1-S64 (janvier 2011)

• 2010

  • Comparative Effectiveness Research-Objectives, Challenges, and Contributions of the US Department of Veterans Affairs

    Volume 123 - Número 12S, pp.A1-A6 (décembre 2010)

  • Current Issues in the Treatment of Type 2 Diabetes

    Volume 123 - Número 3S, pp.S1-S50 (mars 2010)

• 2009

  • Fibromyalgia-The Evolution of New Treatment Strategies for Improving Patient Care

    Volume 122 - Número 12S, pp.S1-S58 (décembre 2009)

  • Recommendations for the Definition, Assessment, and Pharmacologic Management of Neuropathic Pain

    Volume 122 - Número 10S, pp.S1-S38 (octobre 2009)

  • Understanding Human Papillomavirus, Cervical Cancer, and Vaccines: an Educational Resource for Family and General Practitioners

    Volume 122 - Número 8S, pp.S1-S34 (août 2009)

  • Demystifying Incretin Therapy for Type 2 Diabetes

    Volume 122 - Número 6S, pp.S1-S50 (juin 2009)

  • The Potential Role of Nitric Oxide in Cardiovascular Safety when Treating Osteoarthritis in Patients with Hypertension

    Volume 122 - Número 5S, pp.S1-S26 (mai 2009)

  • Role of the Primary Care Physician in Stroke Prevention

    Volume 122 - Numéro 4 Supplément 2, pp.S1-S34 (avril 2009)

  • The Obesity Epidemic: Strategies in Reducing Cardiometabolic Risk

    Volume 122 - Número 4S, pp.S1-S46 (avril 2009)

  • Clinical Issues with Bisphosphonate Therapy for Osteoporosis

    Volume 122 - Número 2S, pp.S1-S48 (février 2009)

  • Management of Atherosclerosis: A Practical Guide in 2008

    Volume 122 - Número 1S, pp.S1-S64 (janvier 2009)

• 2008

  • Optimizing Management Strategies in Patients with Chronic Hepatitis B

    Volume 121 - Número 12S, pp.S1-S62 (décembre 2008)

  • A Primary Care Approach: Managing Depression in the Face of Chronic Medical Conditions

    Volume 121 - Numéro 11 Supplément 2, pp.S1-S48 (novembre 2008)

  • Venous Thromboembolism 2008: The Changing Paradigm of Deep Vein Thrombosis and Pulmonary Embolism Prophylaxis and Treatment

    Volume 121 - Numéro 11 Supplément 1, pp.S1-S42 (novembre 2008)

  • Heightened Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis

    Volume 121 - Numéro 10 Supplément 1, pp.S1-S34 (octobre 2008)

  • Optimizing the Treatment of Benign Prostatic Hyperplasia in African American and Latin American Men

    Volume 121 - Numéro 8 Supplément 2, pp.S1-S42 (août 2008)

  • Management of Hypertension in Patients with Enhanced Cardiovascular Risk

    Volume 121 - Numéro 8 Supplément 1, pp.S1-S34 (août 2008)

  • Expanding the Influenza Vaccination Season: A New Paradigm for Increasing Immunization Rates

    Volume 121 - Numéro 7 Supplément 2, pp.S1-S38 (juillet 2008)

  • Early Identification and Active Management of the Patient with Chronic Obstructive Pulmonary Disease

    Volume 121 - Numéro 7 Supplément 1, pp.S1-S46 (juillet 2008)

  • Optimizing Insulin Therapy for Type 2 Diabetes Mellitus

    Volume 121 - Número 6S, pp.S1-S42 (juin 2008)

  • Diagnostic Error: Is Overconfidence the Problem

    Volume 121 - Número 5S, pp.S1-S48 (mai 2008)

  • Update on Smoking Cessation Interventions for the Primary Care Physician

    Volume 121 - Número 4S, pp.S1-S42 (avril 2008)

• 2007

  • Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations

    Volume 120 - Numéro 11 Supplément 1, pp.S1-S22 (novembre 2007)

  • Management of Venous Thromboembolism

    Volume 120 - Numéro 10 Supplément 2, pp.S1-S42 (octobre 2007)

  • Early Clinical Experiences with Daptomycin for the Treatment of Gram-Positive Infections

    Volume 120 - Numéro 10 Supplément 1, pp.S1-S34 (octobre 2007)

  • Optimizing Cardiovascular Outcomes in Diabetes Mellitus: A Call to Action

    Volume 120 - Numéro 9 Supplément 2, pp.S1-S40 (septembre 2007)

  • Managing Cardiometabolic Risk: Will New Approaches Improve Success?

    Volume 120 - Numéro 9 Supplément 1, pp.S1-S40 (septembre 2007)

  • Creating Optimism in Managing Chronic Obstructive Pulmonary Disease

    Volume 120 - Numéro 8 Supplément 1, pp.S1-S40 (août 2007)

  • Science Policy Roundtable on the Heterogeneity of Treatment Effects

    Volume 120 - Numéro 4 Supplément 1, pp.S1-S38 (avril 2007)

  • Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System and Cannabinoid Receptors

    Volume 120 - Numéro 3 Supplément 1, pp.S1-S42 (mars 2007)

  • Targeting Abdominal Obesity to Reduce Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

    Volume 120 - Numéro 2 Supplément 1, pp.S1-S40 (février 2007)

  • Recognizing and Treating Restless Legs Syndrome: Current Standards

    Volume 120 - Numéro 1 Supplément 1, pp.S1-S36 (janvier 2007)

• 2006

  • Treatment of Congestion in Acute Heart Failure Syndromes: Importance, Strategies, and Challenges

    Volume 119 - Numéro 12 Supplément 1, pp.S1-S44 (décembre 2006)

  • Case Studies in Gouty Arthritis

    Volume 119 - Numéro 11 Supplément 1, pp.S1-S34 (novembre 2006)

  • The Role of Patient-Centered Outcomes in Defining the Clinical Course of Chronic Obstructive Pulmonary Disease

    Volume 119 - Numéro 10 Supplément 1, pp.1-72 (octobre 2006)

  • Genetics and the Sex Steroid Hormone Pathway in Women at Midlife

    Volume 119 - Numéro 9 Supplément 1, pp.S1-S112 (septembre 2006)

  • Hyponatremia: New Understanding, New Therapy

    Volume 119 - Numéro 7 Supplément 1, pp.1-100 (juillet 2006)

  • Antimicrobial Resistance Prevention Initiative: Proceedings of an Expert Panel on Resistance

    Volume 119 - Numéro 6 Supplément 1, pp.S1-S76 (juin 2006)

  • A New Dawn in Cardiovascular Protection III: The Challenge of End-Organ Protection in High-Risk Patients

    Volume 119 - Numéro 5 Supplément 1, pp.S1-S50 (mai 2006)

  • Improving Compliance and Persistence with Osteoporosis Therapies

    Volume 119 - Numéro 4 Supplément 1, pp.S1-S38 (avril 2006)

  • Overactive Bladder: Issues and Management

    Volume 119 - Numéro 3 Supplément 1, pp.1-40 (mars 2006)

• 2005

  • The NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21-23, 2005

    Volume 118 - Numéro 12 Supplément 2, pp.1-172 (décembre 2005)

  • Statin Therapy: Clinical Trials, Guidelines, and New Directions

    Volume 118 - Número 12S, pp.1-68 (décembre 2005)

  • Vaccine-Preventable Hepatitis, a Step Toward Elimination: Reevaluating Hepatitis A and B Prevention

    Volume 118 - Número 10S, pp.1-108 (octobre 2005)

  • The Role of Self Monitoring of Blood Glucose in the Care of People with Diabetes: Report of a Global Consensus Conference

    Volume 118 - Número 9S, pp.1-32 (septembre 2005)

  • Venous Thromboembolic Disease

    Volume 118 - Número 8S, pp.1-36 (août 2005)

  • Recommendations for Accurate Prescribing of Antibiotics: Council for Appropriate and Rational Antibiotic Therapy

    Volume 118 - Número 7S, pp.1-50 (juillet 2005)

  • Pharmacologic Treatment of Type 2 Diabetes Mellitus

    Volume 118 - Número 5S, pp.1-34 (mai 2005)

• 2003

  • Evaluating the Cardiovascular Effects of the Thiazolidinediones and Their Place in the Management of Type 2 Diabetes Mellitus

    Volume 115 - Numéro 8 Supplément 1, pp.1-120 (décembre 2003)

• 2002

  • Atherosclerotic Cardiovascular Disease: New Approaches to Risk Assessment and Intervention

    Volume 112 - Numéro 8 Supplément 1, pp.1-42 (juin 2002)

  • The Emerging Importance of Rhinoviral Respiratory Infections

    Volume 112 - Numéro 6 Supplément 1, pp.1-50 (avril 2002)

• 2001

  • The Patient-Provider Relationship and the Hospitalist Movement

    Volume 111 - Numéro 9 Supplément 2, pp.i-iv (décembre 2001)

  • Respiratory Pathogens in the Community: Prevalence and Treatment

    Volume 111 - Numéro 9 Supplément 1, pp.1-42 (décembre 2001)

  • Third Multi-Disciplinary International Symposium on Supraesophageal Complications of Reflux Disease

    Volume 111 - Numéro 8 Supplément 1, pp.1-220 (décembre 2001)

  • Use of Beta-Blocker Therapy for Mild-to-Moderate Chronic Heart Failure

    Volume 110 - Numéro 7 Supplément 1, pp.i-x (mai 2001)

  • Reaching National Cholesterol Goals: A Managed Care Approach to Improving Hyperlipidemia Disease Management Outcomes

    Volume 110 - Numéro 6 Supplément 1, pp.1-34 (avril 2001)

  • The Role of COX-2-Specific Inhibitors in Clinical Practice

    Volume 110 - Numéro 3 Supplément 1, pp.1-56 (février 2001)

  • Nonsteroidal Anti-Inflammatory Drugs and the Gastrointestinal Tract: Consensus and Controversy

    Volume 110 - Numéro 1 Supplément 1, pp.S1-S100 (janvier 2001)

• 2000

  • New Perspectives on Managing Erectile Dysfunction in Primary Care

    Volume 109 - Numéro 9 Supplément 1, pp.1-34 (décembre 2000)

• 1997

  • Advances in the Epidemiology, Prevention, and Treatment of Osteoporosis and Fractures

    Volume 103 - Numéro 2 Supplément 1, pp.S1-S92 (août 1997)

• 1996

  • is 6A

    Volume 100 - Numéro 6 Supplément 1, pp.1S-95S (juin 1996)

  • Obstructive Airways Disease: Antimuscarinic Bronchodilator therapy

    Volume 100 - Supplément 1, pp.S1-S70 (janvier 1996)

• 1995

  • National Clinical Conference on Lyme Disease

    Volume 98 - Numéro 4 Supplément 1, pp.1S-89S (avril 1995)

  • Proceedings of a Symposium Osteoporosis: Who Should be Treated?

    Volume 98 - Numéro 2 Supplément 1, pp.1S-88S (février 1995)

• 1988

  • Well-Being, Hypertension, and Indapamide Proceedings of the XVth International Meeting

    Volume 84 - Supplément 1, pp.1-111 (janvier 1988)

• 1974

  • Third F. Raymond Keating, Jr., Memorial Symposium-Parathyroid Hormone, Calcitonin and Vitamin D: Clinical Considerations (Part II)

    Volume 57 - Número 1, pp.A1-A24 (juillet 1974)

  • Third F. Raymond Keating, Jr., Memorial Symposium\3-Parathyroid Hormone, Calcitonin and Vitamin D: Clinical Considerations (Part I)

    Volume 56 - Número 6, pp.A1-A6 (juin 1974)